1. Home
  2. VYGR
  3. VYGR News

Latest Voyager Therapeutics Inc. (VYGR) News on December 23, 2024

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025
VYGR

Zacks

6 days ago

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
VYGR

Simply Wall St.

11 days ago

Institutional investors own a significant stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?
VYGR

Zacks

19 days ago

Wall Street Analysts See a 152.53% Upside in Voyager Therapeutics (VYGR): Can the Stock Really Move This High?

Wedbush upgrades Voyager to Outperform on pipeline progress
VYGR

TipRanks

23 days ago

Wedbush upgrades Voyager to Outperform on pipeline progress

VYGR

MT Newswires

24 days ago

Wedbush Upgrades Voyager Therapeutics to Outperform From Neutral, Raises Price Target to $11 From $7

VYGR

MT Newswires

a month ago

Voyager Therapeutics Selects Development Candidate for Tau Silencing Program in Alzheimer's Disease

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
VYGR

GlobeNewswire

a month ago

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?
VYGR

Simply Wall St.

a month ago

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?

VYGR

Thomson Reuters StreetEvents

a month ago

Q3 2024 Voyager Therapeutics Inc Earnings Call

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
VYGR

GuruFocus.com

a month ago

Voyager Therapeutics Inc (VYGR) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates
VYGR

Zacks

a month ago

Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

a month ago

Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Reports Third Quarter 2024 Financial and Operating Results
VYGR

GlobeNewswire

a month ago

Voyager Reports Third Quarter 2024 Financial and Operating Results

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
VYGR

GlobeNewswire

2 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
VYGR

GlobeNewswire

2 months ago

Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
VYGR

Zacks

2 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
VYGR

Zacks

2 months ago

Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

VYGR

MT Newswires

2 months ago

Leerink Partners Initiates Voyager Therapeutics at Outperform With $15 Price Target

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain
VYGR

Simply Wall St.

2 months ago

Investing in Voyager Therapeutics (NASDAQ:VYGR) three years ago would have delivered you a 58% gain

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?
VYGR

Zacks

2 months ago

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
VYGR

Zacks

3 months ago

Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?

VYGR

MT Newswires

3 months ago

Voyager Therapeutics Says Third Gene Therapy Development Candidate Selected Under Neurocrine Collaboration

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected
VYGR

GlobeNewswire

3 months ago

Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected

Novartis to License VYGR's Capsid for Gene Therapy in Neurology
VYGR

Zacks

4 months ago

Novartis to License VYGR's Capsid for Gene Therapy in Neurology

VYGR

MT Newswires

4 months ago

Voyager Therapeutics Gets Capsid License for Gene Therapy Program From Novartis

Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
VYGR

GlobeNewswire

4 months ago

Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VYGR

GlobeNewswire

4 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences
VYGR

GlobeNewswire

4 months ago

Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
VYGR

Simply Wall St.

4 months ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates
VYGR

Zacks

5 months ago

Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

5 months ago

Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results

Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VYGR

GlobeNewswire

5 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is definitely on the radar of institutional investors who own 49% of the company
VYGR

Simply Wall St.

6 months ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) is definitely on the radar of institutional investors who own 49% of the company

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences
VYGR

GlobeNewswire

6 months ago

Voyager Therapeutics to Present at Multiple Virtual Investor Conferences

VYGR

MT Newswires

6 months ago

Voyager Therapeutics Names Nathan Jorgensen as Finance Chief

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer
VYGR

GlobeNewswire

6 months ago

Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
VYGR

GOBankingRates

6 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
VYGR

AFP

6 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
VYGR

AFP

6 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
VYGR

AFP

6 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
VYGR

Business Insider

6 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
VYGR

Insider Monkey

6 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
VYGR

Reuters

6 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

VYGR

Insider Monkey

6 months ago

Best Date Night Fragrance in 2024

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
VYGR

GlobeNewswire

7 months ago

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

VYGR

Thomson Reuters StreetEvents

7 months ago

Q1 2024 Voyager Therapeutics Inc Earnings Call

VYGR

MT Newswires

7 months ago

Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating

VYGR

GuruFocus.com

7 months ago

Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...

Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
VYGR

Zacks

7 months ago

Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates

VYGR

Associated Press Finance

7 months ago

Voyager Therapeutics: Q1 Earnings Snapshot

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
VYGR

GlobeNewswire

7 months ago

Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
VYGR

GlobeNewswire

7 months ago

Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns
VYGR

Simply Wall St.

8 months ago

Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
VYGR

Zacks

8 months ago

Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
VYGR

Zacks

8 months ago

Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
VYGR

GlobeNewswire

8 months ago

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
VYGR

Simply Wall St.

8 months ago

Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.
VYGR

Barrons.com

9 months ago

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VYGR

GlobeNewswire

9 months ago

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
VYGR

GlobeNewswire

9 months ago

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
VYGR

Insider Monkey

9 months ago

12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds

Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts
VYGR

Simply Wall St.

10 months ago

Analysts Just Made A Major Revision To Their Voyager Therapeutics, Inc. (NASDAQ:VYGR) Revenue Forecasts

VYGR

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Voyager Therapeutics Inc Earnings Call

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript
VYGR

Insider Monkey

10 months ago

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Q4 2023 Earnings Call Transcript

Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position
VYGR

GuruFocus.com

10 months ago

Voyager Therapeutics Inc (VYGR) Announces Strong Year-End Financials with Significant Cash Position

VYGR

Associated Press Finance

10 months ago

Voyager Therapeutics: Q4 Earnings Snapshot

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?
VYGR

Zacks

10 months ago

Novavax (NVAX) Surges 8.4%: Is This an Indication of Further Gains?

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
VYGR

GlobeNewswire

10 months ago

Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference
VYGR

GlobeNewswire

a year ago

Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference

Dave Ramsey: 10 Genius Things To Do With Your Money
VYGR

GOBankingRates

a year ago

Dave Ramsey: 10 Genius Things To Do With Your Money

CoStar Group to Report Financial Results for Fourth Quarter and Full Year 2023 on February 20, 2024
VYGR

Business Wire

a year ago

CoStar Group to Report Financial Results for Fourth Quarter and Full Year 2023 on February 20, 2024

Kearny Financial Corp. Revises Second Quarter Fiscal 2024 Results
VYGR

GlobeNewswire

a year ago

Kearny Financial Corp. Revises Second Quarter Fiscal 2024 Results

Amazon's abandoned acquisition leaves iRobot in Carlyle debt straightjacket
VYGR

Reuters

a year ago

Amazon's abandoned acquisition leaves iRobot in Carlyle debt straightjacket

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis
VYGR

GlobeNewswire

a year ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

VYGR

Business Wire

a year ago

Cohu Provides Business Update for Fourth Quarter 2023, Date for Earnings Call and Preliminary First Quarter 2024 Guidance

Cohu's (NASDAQ:COHU) investors will be pleased with their notable 90% return over the last five years
VYGR

Simply Wall St.

a year ago

Cohu's (NASDAQ:COHU) investors will be pleased with their notable 90% return over the last five years

While institutions own 30% of Voyager Therapeutics, Inc. (NASDAQ:VYGR), individual investors are its largest shareholders with 42% ownership
VYGR

Simply Wall St.

a year ago

While institutions own 30% of Voyager Therapeutics, Inc. (NASDAQ:VYGR), individual investors are its largest shareholders with 42% ownership

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA
VYGR

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Universal Logistics Holdings to Report Fourth Quarter 2023 Earnings on Thursday, February 15, 2024
VYGR

PR Newswire

a year ago

Universal Logistics Holdings to Report Fourth Quarter 2023 Earnings on Thursday, February 15, 2024

VYGR

Associated Press Finance

a year ago

QCR Holdings: Q4 Earnings Snapshot

QCR Holdings, Inc. Announces Record Net Income of $32.9 Million for the Fourth Quarter and Record Net Income of $113.6 Million for the Full Year 2023
VYGR

GlobeNewswire

a year ago

QCR Holdings, Inc. Announces Record Net Income of $32.9 Million for the Fourth Quarter and Record Net Income of $113.6 Million for the Full Year 2023

Metropolitan Bank Holding Corp. (NYSE:MCB) Q4 2023 Earnings Call Transcript
VYGR

Insider Monkey

a year ago

Metropolitan Bank Holding Corp. (NYSE:MCB) Q4 2023 Earnings Call Transcript

Westlake Chemical Partners LP Announces Fourth Quarter 2023 Distribution
VYGR

Business Wire

a year ago

Westlake Chemical Partners LP Announces Fourth Quarter 2023 Distribution

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?
VYGR

Simply Wall St.

a year ago

Is GrafTech International Ltd. (NYSE:EAF) Potentially Undervalued?

Cognyte Announces New Release of LUMINAR Cyber Threat Intelligence Offering with GenAI Capabilities to Bring Added Value to Customers
VYGR

Business Wire

a year ago

Cognyte Announces New Release of LUMINAR Cyber Threat Intelligence Offering with GenAI Capabilities to Bring Added Value to Customers

Got $1,000? 3 Top Growth Stocks to Buy That Could Double Your Money.
VYGR

Motley Fool

a year ago

Got $1,000? 3 Top Growth Stocks to Buy That Could Double Your Money.

Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know
VYGR

Zacks

a year ago

Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know

VYGR

GlobeNewswire

a year ago

Titan Machinery Elects New Board Member

Can Business First (BFST) Keep the Earnings Surprise Streak Alive?
VYGR

Zacks

a year ago

Can Business First (BFST) Keep the Earnings Surprise Streak Alive?

Vivid Seats Named a 2024 Best Place to Work
VYGR

GlobeNewswire

a year ago

Vivid Seats Named a 2024 Best Place to Work

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode
VYGR

InvestorPlace

a year ago

Small-Cap Surprises: 7 Undiscovered Growth Stocks Poised to Explode

Share on Social Networks: